NCT06971848 2026-03-30
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
Clinical Trials
31 trialsNCT07477912 2026-03-17
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Recruiting
NCT07457112 2026-03-09
EHCancer
Zagazig University
Phase NA Completed
NCT07413809 2026-02-17
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT07139509 2025-11-25
UCAR-T_MM-XA
Xi'an No.3 Hospital
Phase 1 Recruiting
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT07085559 2025-07-25
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT04790474 2025-07-24
IPoD-790
Tel-Aviv Sourasky Medical Center
Phase 2 Active not recruiting
NCT04813653 2025-07-24
Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells
Tel-Aviv Sourasky Medical Center
Phase 1 Completed
NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT06520176 2024-07-25
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT06515249 2024-07-23
Integrative Therapies in Multiple Myeloma
Bnai Zion Medical Center
Phase NA Recruiting
NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT05697913 2024-03-06
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Hospital Galdakao-Usansolo
Phase NA Unknown
NCT06262789 2024-02-16
RAT-HEMATO
University Hospital, Angers
Phase NA Not yet recruiting
NCT05243212 2024-01-31
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Sheba Medical Center
Phase 1/2 Recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting
NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
NCT04065789 2022-01-27
KyDaR
Tel-Aviv Sourasky Medical Center
Phase 2 Completed
NCT02773550 2020-01-18
Velcadito
Basque Health Service
Phase 4 Terminated
NCT03908138 2019-11-29
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
Phase 4 Unknown
NCT03601624 2018-11-14
MM-POM-2018
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase 2 Unknown
NCT03664661 2018-09-10
BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma
Henan Cancer Hospital
Phase 1 Unknown
NCT03322735 2017-12-29
Study of BCMA CAR-T in Multiple Myeloma
Henan Cancer Hospital
Phase 1/2 Unknown
NCT02488382 2017-10-17
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Phase 1/2 Unknown
NCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT00412919 2013-12-16
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
Bayside Health
Phase 2 Terminated
NCT00872352 2009-03-31
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients
Wolfson Medical Center
Phase 3 Unknown
NCT00207805 2009-01-27
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
Centre National de Greffe de Moelle Osseuse
Phase 3 Completed
NCT00164086 2006-10-11
Atorvastatin in Myeloma
Bayside Health
Phase 1 Unknown